Designing a ligand for pharmaceutical purposes - Wikidata - awgldk - TriplyDB

Designing a ligand for pharmaceutical purposes

Designing a ligand for pharmaceutical purposes

http://www.wikidata.org/entity/Q56979637

about

ClickMD: an intuitive web-oriented molecular dynamics platform.A Novel Generalized 3D-QSAR Model of Camptothecin Analogs

P2860

Q39735330-DC4FE0AB-96A2-44D7-BA7F-F7E189B2A6CA Q56979547-3E86FAE2-4131-498C-9FE0-B44A8650410B

P2860

Designing a ligand for pharmaceutical purposes

http://www.wikidata.org/entity/Q56979637

description

im April 2008 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2008

@uk

name

Designing a ligand for pharmaceutical purposes

@en

Designing a ligand for pharmaceutical purposes

@nl

type

label

Designing a ligand for pharmaceutical purposes

@en

Designing a ligand for pharmaceutical purposes

@nl

prefLabel

Designing a ligand for pharmaceutical purposes

@en

Designing a ligand for pharmaceutical purposes

@nl

P1433

Q56979637-BDEDD49A-BD79-4916-B12B-20771C55C7F4

P1476

Q56979637-B86AC1D0-0B3E-4B9D-B0A8-EA04215B5608

P2093

Q56979637-3EB24121-3987-4353-91D0-C45F2183F4A3

P2860

Q56979637-00DE09F3-86C5-43FE-AA60-25E974BDBB43

Q56979637-0102095B-14B1-460C-BB2E-9F47392027D6

Q56979637-0226B4E9-0496-463A-A3EF-5DB512954B96

Q56979637-0567759E-E1E2-4C1D-9C96-1133C8B6AC56

Q56979637-08C93A53-21DC-445D-92D3-669E74C15E02

Q56979637-0CBFACC0-9AE7-49C3-91D0-676DA535F69C

Q56979637-0DCB36B2-6611-4EA9-843B-A29F9D6D72BC

Q56979637-19A58161-8E7C-4A03-A077-52402D14F4B5

Q56979637-1A1FCE5B-9A87-4C4C-84F0-680B963BC76C

Q56979637-1A7252D6-936F-48A1-A86A-4112DB3F3C0E

P304

Q56979637-40664898-890C-419A-B08A-3FB2429B9AED

P31

Q56979637-5CBB334E-C26D-452B-9EC2-2175DED4E166

P356

Q56979637-EAC41A28-13F8-4800-B003-EA990206C4B5

P407

Q56979637-738D1E0F-F6E6-4024-9B79-27B6F9F51280

P433

Q56979637-4BF6644F-28C3-432E-B2F8-08D7516EA31A

P478

Q56979637-D08C9A3A-A74D-4B11-9C29-9E7ADD408AD2

P50

Q56979637-37CE2D79-69E7-4C4B-8830-76BEE4C42E84

P577

Q56979637-B280C560-71FC-4E01-B980-C6E8E0AAD4F0

P698

Q56979637-52A8AC6E-2F94-4490-9285-4A0A963A6837

P356

17460441.3.5.579

P1433

Expert Opinion on Drug Discovery

P1476

Designing a ligand for pharmaceutical purposes

@en

P2093

Andrea Bortolato

http://www.w3.org/2001/XMLSchema#string

P2860

Advances in Homology Protein Structure Modeling

The Protein Data Bank

Nucleoside binding site of herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography

The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules

Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships

Rescoring Docking Hit Lists for Model Cavity Sites: Predictions and Experimental Testing

Gaussian docking functions

Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

PMF scoring revisited

P304

579-590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17460441.3.5.579

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23484928

http://www.w3.org/2001/XMLSchema#string